This inventor holds 2 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 1999-2003.
Location History:
- Madison, WI (US) (1999)
- San Diego, CA (US) (2003)
Company Filing History:
Years Active: 1999-2003
Title: Innovations of Lu-Shiun Her in Nucleocytoplasmic Transport
Introduction
Lu-Shiun Her is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of molecular biology, particularly in the area of nucleocytoplasmic transport. With a total of 2 patents, his work has implications for understanding viral mechanisms and cellular processes.
Latest Patents
Lu-Shiun Her's latest patents focus on the inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides. One patent discloses a fragment of the vesicular stomatitis virus (VSV) matrix protein that can inhibit the transport of RNA, proteins, and RNA-protein complexes. These polypeptide products can be utilized to impede nucleocytoplasmic transport. Additionally, fragments of the VSV M protein that can enter the nucleus of a cell are also disclosed. These fragments, along with the full-length VSV M protein, can be employed to introduce other polypeptides into the nucleus. Another patent outlines a method for inhibiting the transport of nucleic acids between the nucleus and cytoplasm of a cell. This method involves exposing a cell to a sufficient amount of vesicular stomatitis virus M protein to impede the transport of RNA and protein through the nuclear envelope.
Career Highlights
Lu-Shiun Her is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in therapeutic strategies against viral infections and cellular transport mechanisms.
Collaborations
Some of his notable coworkers include James E. Dahlberg and Elsebet Lund, who have contributed to his research endeavors.
Conclusion
Lu-Shiun Her's innovative work in the field of nucleocytoplasmic transport showcases the intersection of virology and molecular biology. His patents reflect a commitment to advancing scientific knowledge and potential therapeutic applications.